CDC Reports 58 New Measles Cases as Nationwide Count Surpasses 200

Seeking Alpha12:52 ET

CDC Plans to Study Possible Link Between Vaccines and Autism - Report

Seeking Alpha11:51 ET

Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251

BenzingaMar 6 13:18 ET

FDA Chief Nominee Makary Pledges to 'Review' Cancellation of Vaccine Panel Meeting

Seeking AlphaMar 6 12:07 ET

GSK to Showcase Latest Research at the International RSV Symposium to Advance RSV Prevention in Adults

GSK PlcMar 6 00:00 ET

ViiV Healthcare Announces That Quebec Has Become The First Province To Publicly Reimburse APRETUDE For Pre-Exposure Prophylaxis To Reduce The Risk Of Sexually Acquired HIV-1 Infection In At-Risk Individuals Who Are HIV-1 Negative

BenzingaMar 5 10:07 ET

Measles Outbreak in Texas Leads to 159 Cases

Seeking AlphaMar 4 15:17 ET

GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report

BenzingaMar 4 14:20 ET

European Equities Traded in the US as ADRs Fall in Tuesday Trading

MT NewswiresMar 4 11:07 ET

Top HHS Spokesman Tom Corry Abrupty Resigns

Seeking AlphaMar 3 15:13 ET

6-K: Gsk Plc 2024 Annual Report on Form 20-F

SECMar 3 12:47 ET · Announcements

GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review

BenzingaMar 3 11:54 ET

Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis

BenzingaMar 3 11:49 ET

20-F: FY2024 Annual Report

SECMar 3 11:05 ET · Announcements

The FDA Has Accepted For Review GSK's Biologics License Application For The Use Of Depemokimab In Two Indications, The Prescription Drug User Fee Act Date Is 16 December 2025

BenzingaMar 3 05:32 ET

Express News | On Saturday, GSK Announced Full Results From ANCHOR-1 and ANCHOR-2 Phase 3 Trials Assessing The Efficacy And Safety Of Depemokimab Versus Placebo In Adults With Chronic Rhinosinusitis With Nasal Polyps

BenzingaMar 3 05:30 ET

GlaxoSmithKline (GSK) Gets a Hold From Barclays

TipRanksMar 3 02:01 ET · Ratings

Is GSK Plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?

Yahoo FinanceMar 3 00:40 ET

Depemokimab Applications Accepted for Review by the US FDA for Asthma With Type 2 Inflammation and for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

GSK PlcMar 3 00:00 ET

Notable Healthcare Headlines for the Week: Viatris, J&J, Walgreens Boots Alliance Teladoc Health and Pfizer in Focus

Seeking AlphaMar 2 11:05 ET